MREO

NASD Mereo BioPharma Group plc Sponsored ADR
Oct 9, 2026 · 9:23 AM ET LAST TRADE Market Closed

$0.3805 ↑ +0.0053 (+1.41%) Trading Up from the previous close of $0.3752

YTD change
-8.69%
vs 20-day SMA
+13.31%
vs 200-day SMA
-0.79%

Price ranges

Previous day
$0.3407 $0.3825
open $0.3500 close $0.3752
+$0.0252 (+7.20%)
Today
$0.0000 $0.0000
$0.3805
Past week
$0.3407 $0.4030
from $0.3669 now $0.3805
+$0.0136 (+3.71%)
Past month
$0.2446 $0.4232
from $0.2446 now $0.3805
+$0.1359 (+55.56%)
This year
$0.2200 $0.7800
from $0.4167 now $0.3805
-$0.0362 (-8.69%)

Price & Performance

+0.06 (+17.25%) / 6M

$0.2240$0.2877$0.3515$0.4152Apr 9Jul 10Oct 8

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 95.5% away from all-time highs of $8.4800
  • MREO is down 9% since the beginning of the year
  • MREO is down 82% over the past 12 months
  • MREO is up 56% over the past 1 month
  • 2% of all MREO investors are betting against MREO

MREO reads neutral: price sits above one of the two key moving averages, the 12-month move is -82.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.01
Earnings momentum +38.8% Quarterly EPS growth
Quarterly change +38.8%

Valuation

P/E ratio N/A
Enterprise value $31.2M
Beta 0.01

Balance sheet & scale

IncomeN/A
Revenue$-3129.0
Cash$30.1M
Debt$1.0K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $60.8M

Mereo BioPharma Group Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its portfolio include Etigilimab (MPH-313), Alvelestat (MPH-966), Setrusumab (BPS-804), Navicixizumab (OMP-305B83), Acumapimod (BCT-197), and Leflutrozole (BGS-649). The company was founded by Denise Vera Scots-Knight, Charles Edward Sermon, Alastair Graham MacKinnon, and John P. Richard in March 10, 2015 and is headquartered in London, the United Kingdom.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,169.60 -1.61%
JNJ Johnson & Johnson $256.48 -0.76%
ABBV AbbVie, Inc. $272.42 +0.39%
MRK Merck & Co., Inc. $142.38 -0.29%
RHHBY Roche Holding Ltd Sponsored ADR $53.37 -1.29%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.